CTRP2 Activators
The classification of CTRP2 activators encompasses a diverse array of chemical compounds that initiate cellular signaling pathways resulting in the upregulation or functional enhancement of CTRP2, an adipokine involved in various metabolic processes. These activators are not directly binding to CTRP2 but are engaging in upstream modulation of pathways that govern its expression and function. For instance, compounds such as Metformin and AICAR, known for their AMPK-activating properties, are integral to the adjustment of cellular energy balance. They instigate a complex signaling cascade that fosters an environment conducive to the transcriptional upregulation of CTRP2, affirming its role in metabolic regulation. This effect is indicative of the cell's broader adaptive response to changes in energy availability, where CTRP2 expression is adjusted to meet the altered metabolic demand.
Similarly, the PPAR agonists, including Rosiglitazone, Pioglitazone, Bezafibrate, Fenofibrate, and Telmisartan, provide a mechanistic avenue for CTRP2 modulation through their regulatory influence over genes linked to glucose and lipid homeostasis. By binding to PPAR receptor subtypes, these compounds elicit transcriptional programs that include the expression of CTRP2, aligning it with pathways that control metabolic equilibrium and energy expenditure. Resveratrol's activation of SIRT1, subsequently engaging AMPK, exemplifies another modulatory sequence that can culminate in increased CTRP2 levels, highlighting the interplay between cellular energy sensors and metabolic gene expression. The involvement of DHA underscores the intersection between dietary components and metabolic gene regulation, offering insights into how nutritional status can interface with the regulation of adipokines such as CTRP2. Berberine's role in this class further underscores the capacity of certain bioactive compounds to activate key regulatory kinases like AMPK, thereby influencing the metabolic profile of a cell, including the modulation of proteins such as CTRP2. Collectively, these CTRP2 activators represent a spectrum of biochemical agents that, through their individual actions on distinct molecular targets and pathways, contribute to the regulatory network governing CTRP2, reflecting its integration within the complex system of metabolic control.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin activates AMP-activated protein kinase (AMPK), a regulator of cellular energy homeostasis. AMPK activation can lead to transcriptional changes enhancing the expression of CTRP2, given its role in metabolic processes. Through AMPK's broad regulatory reach, it orchestrates the enhancement of cellular pathways that upregulate energy-sensing proteins, including CTRP2, as part of the homeostatic response to altered energy states. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR is an adenosine analog that stimulates AMPK, and through AMPK activation, it can increase the expression of genes involved in fatty acid oxidation and mitochondrial biogenesis, including CTRP2. AICAR-driven AMPK activation enacts a shift in cellular metabolism that can elevate CTRP2 levels as part of the adaptive response to enhanced energetic demands. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone is a PPAR-gamma agonist that modulates the transcription of genes implicated in glucose and lipid metabolism. By stimulating PPAR-gamma, it can indirectly enhance the expression of CTRP2, which is associated with these metabolic processes. PPAR-gamma's transcriptional control extends to proteins like CTRP2, linking metabolic regulation with the potential upregulation of CTRP2. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone, similar to Rosiglitazone, activates PPAR-gamma, impacting gene transcription tied to metabolism. Activation of PPAR-gamma can lead to an increase in CTRP2 expression as it participates in the regulatory network controlling glucose and fatty acid homeostasis. Through the modulation of PPAR-gamma target genes, Pioglitazone can contribute to the heightened expression of CTRP2. | ||||||
AICA-Riboside, 5′-Phosphate | 3031-94-5 | sc-202448B sc-202448C sc-202448 sc-202448A | 5 mg 10 mg 50 mg 100 mg | $184.00 $281.00 $505.00 $938.00 | 1 | |
AICAR, through its activation of AMPK, can indirectly boost CTRP2 levels. AMPK serves as a metabolic master switch that can initiate a cascade of events promoting the expression of genes involved in energy balance and metabolism, among which CTRP2 is a key component. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $31.00 $46.00 $122.00 $204.00 | 5 | |
Bezafibrate activates PPARs (alpha, gamma, and delta), broadening its influence on genes controlling lipid metabolism and energy expenditure, potentially affecting the levels of CTRP2 as part of this regulation. The comprehensive reach of PPARs under bezafibrate's influence includes modulatory effects on proteins like CTRP2 that are implicated in metabolic processes. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fenofibrate is another PPAR-alpha agonist, stimulating the transcription of genes implicated in fatty acid metabolism. By engaging PPAR-alpha, it may indirectly contribute to the regulation and expression of CTRP2, given the protein's involvement in lipid and glucose metabolism. PPAR-alpha activation by Fenofibrate aligns with the increased expression of proteins, such as CTRP2, that play a role in maintaining metabolic equilibrium. | ||||||
Telmisartan | 144701-48-4 | sc-204907 sc-204907A | 50 mg 100 mg | $72.00 $94.00 | 8 | |
Telmisartan, an angiotensin II receptor antagonist, also exhibits PPAR-gamma agonistic properties. By activating PPAR-gamma, Telmisartan can lead to transcriptional effects that may enhance CTRP2 expression, given the protein's metabolic role. Telmisartan's effect on PPAR-gamma potentially extends to the augmentation of CTRP2, reflecting the intricate link between cardiovascular regulation and metabolic control. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol stimulates SIRT1, an NAD+-dependent deacetylase, which in turn activates AMPK. SIRT1-AMPK signaling has implications for the expression of metabolic genes, including those encoding CTRP2. The chain of activation from Resveratrol to SIRT1, and subsequently to AMPK, underlies a pathway conducive to the enhancement of CTRP2 expression as part of the cellular energy response mechanism. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Berberine has been shown to activate AMPK. AMPK activation initiates a downstream signaling cascade that can enhance CTRP2 expression due to its role in regulating glucose and lipid metabolism. The pharmacological action of Berberine on AMPK, therefore, extends to the modulation of CTRP2 expression as part of the broader influence on energy homeostasis. | ||||||